Home infusions of natalizumab for people with multiple sclerosis: a pilot randomised crossover trial

OBJECTIVE: The delivery of healthcare at home has expanded to intravenous infusions of monoclonal antibodies. A recently developed model of care for home infusions of natalizumab for people with relapsing‐remitting multiple sclerosis was evaluated. This pilot study of home infusions of natalizumab a...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultz, Timothy J., Thomas, Anne, Georgiou, Paul, Juaton, Mahasen S., Cusack, Lynette, Simon, Lorraine, Naidoo, Kerisha, Webb, Kevin, Karnon, Jonathan, Ravindran, Janakan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351394/
https://www.ncbi.nlm.nih.gov/pubmed/34288591
http://dx.doi.org/10.1002/acn3.51410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351394/
https://www.ncbi.nlm.nih.gov/pubmed/34288591
http://dx.doi.org/10.1002/acn3.51410

Ejemplares similares